Item 9 Labs Corp. (INLB)

0.0001 0.0000 (0.00%) As of 09:30AM EDT. Market open.

Item 9 Labs Corp.

2727 North 3rd Street
Suite 201
Phoenix, AZ 85004
United States
833 867 6337
https://www.item9labscorp.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 97

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Robert E. Mikkelsen	Secretary, Treasurer & CFO	263.68k	N/A	1982
Mr. Christopher Leland Wolven	Chief Operating Officer	256.45k	N/A	1983
Mr. Jeffrey I. Rassas	Strategic Advisor & Director	176.58k	N/A	1963
Ms. Jayne Levy	Senior Vice President of Communications	N/A	N/A	N/A
Kyle Jennings	Vice President of Marketing	N/A	N/A	N/A
Mr. Mark Busch	Senior Vice President of Corporate Development	N/A	N/A	N/A
Mr. Cory Carter	Senior Vice President of Cultivation	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.

Corporate Governance

Item 9 Labs Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.